![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | 2024 31/03 |
2023 31/12 |
2023 30/09 |
2023 30/06 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 308.25 | 469.38 | 335.06 | 326.35 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 252.47 | 318.32 | 274.42 | 247.71 | ||||||||||||||||||||||||||||||
Gross Profit | 55.78 | 151.07 | 60.64 | 78.63 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 294.78 | 352.64 | 310.05 | 287.53 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 13.47 | 116.75 | 25.01 | 38.81 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | 0.041 | 0.023 | 0.749 | 2.83 | ||||||||||||||||||||||||||||||
Other, Net | -4.75 | 20.37 | 17.25 | 14.48 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 18.18 | 96.35 | 7.02 | 21.5 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 4.84 | 16.09 | 4.33 | 5.2 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 13.34 | 80.26 | 2.69 | 16.3 | ||||||||||||||||||||||||||||||
Minority Interest | 306.38 | 279.71 | 103.64 | 106.28 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 7.5 | 63.01 | 5.33 | 12.6 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 7.5 | 63.01 | 5.33 | 12.6 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 7.5 | 63.01 | 5.33 | 12.6 | ||||||||||||||||||||||||||||||
Dilution Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Net Income | 7.5 | 63.01 | 5.33 | 12.6 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 2832.96 | 2832.96 | 2805.36 | 2800.63 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 0.003 | 0.022 | 0.002 | 0.004 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.002 | 0.015 | 0.006 | 0.003 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review